China News Service, Shanghai, March 7 (Reporter Chen Jing) On the 7th, the Shanghai Cord Blood Bank and the Hematology Department of the Children's Hospital of Suzhou University (hereinafter referred to as Suzhou Children's Hospital) completed a special hematopoietic stem cell transplant using Xiaobao's umbilical cord. Hematopoietic stem cells were used to treat Dabao's leukemia.
In September 2023, a 10-year-old girl Xiaomeng (pseudonym) sought medical treatment locally due to unexplained fever that lasted for more than a week.
Routine blood tests showed a sharp increase in white blood cells and a severe decrease in red blood cells and platelets. The doctor suspected that Xiao Meng was suffering from a blood disease. After bone puncture, she was finally diagnosed with acute myeloid leukemia.
After that, Xiao Meng began to receive chemotherapy at the Children's Hospital of Soochow University. The brave and strong Xiao Meng successfully survived the chemotherapy every time and achieved complete remission in the second course of treatment.
At this time, Xiaobao is about to reach full term in his mother's belly. Director Hu Shaoyan of the Hematology Department of Children's Hospital Affiliated to Suzhou University suggested that parents save Xiaobao's umbilical cord blood and use it to match Dabao; if it matches, Xiaobao can be used The cord blood was given to Dabao for a hematopoietic stem cell transplant.
The Shanghai Cord Blood Bank stored the second baby's cord blood for Xiaomeng's parents and conducted an HLA matching test. The results showed that Xiaobao's cord blood was a perfect match for Dabao.
Xiaobao’s umbilical cord blood saves Dabao.
(Photo courtesy of Shanghai Cord Blood Bank)
The team of doctors formulated a transplant plan for Xiao Meng, using her father's bone marrow, his father's hematopoietic stem cells, and Xiao Bao's cord blood in a multi-pronged approach, hoping to cure Xiao Meng's leukemia.
Professor Hu Shaoyan introduced that childhood myeloid leukemia is not uncommon among children with hematological diseases. Xiaomeng’s entire treatment process after the diagnosis of the disease was relatively smooth, and she had the opportunity to undergo a transplant in less than half a year. This time point is also the best time. The best time for transplantation.
"Our team of doctors carefully selected the transplant plan for the patient. We hope that Xiaomeng can rebuild her hematopoietic system and immune system and gain a new life after the transplant. We also believe that many patients who have received transplants can return to school well after being reborn. Return to family and society," she said.
It is understood that the Shanghai Cord Blood Bank has achieved a 100% matching success rate for Chinese patients around the world.
The five-year survival rate of acute leukemia haploid transplantation combined with cord blood transplantation completed by Shanghai Cord Blood Bank and the Children's Hospital of Soochow University is over 80%, reaching the internationally advanced level.
This not only represents the latest achievements in China's stem cell treatment technology, but also fully reflects the medical value of umbilical cord blood as an important biological resource.
(over)